The effect of letrozole in combination with misoprostol on induced abortion success rate

Phase 3

• Conditions: induced abortion.; Pregnancy with abortive outcome

• Registration Number: IRCT2017011526962N3
• Lead Sponsor: Vice Chancellor for Research Urmia university of medical sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 78

Inclusion Criteria

patients more than 18 years of age, pregnancy in 14 or less than 14 weeks (will be on firmed by ultrasonography), Hb above 10, diastolic blood pressure of below 95 mm Hg
Exclusion criteria: Adrenal gland failure, cancer, porphyria, thromboembolism, severe hepatic diseases, bronchial asthma, hypertension, breast feeding, hepatic function tests disorders, blood tests disorders, consumption of any medicine

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete abortion. Timepoint: After intervention. Method of measurement: will be on firmed by ultrasonography.;The duration of induction to complete expulsion of products of conception. Timepoint: The interval between the consumer misoprostol l until the abortion. Method of measurement: Hours.

Secondary Outcome Measures

Name	Time	Method
The need for surgical abortion in the two groups. Timepoint: During intervention. Method of measurement: will be on firmed by ultrasonography.;The consumer misoprostol in two groups. Timepoint: During intervention. Method of measurement: The number of vaginal tablets used.;Age patients. Timepoint: During intervention. Method of measurement: Year.;Gestational age. Timepoint: The duration from the last period. Method of measurement: Week.